Literature DB >> 11241724

Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease.

D Aarsland1, J L Cummings, J P Larsen.   

Abstract

OBJECTIVE: To compare the profile of neuropsychiatric symptoms in patients with Parkinson's disease with dementia (PDD) and patients with Alzheimer's disease (AD).
DESIGN: Cross-sectional survey of a population-based sample of patients with PDD and AD patients matched for age, sex, and Mini-Mental State Examination (MMSE) score.
METHOD: Patients were diagnosed according to published criteria for PD and AD. The diagnosis of dementia in PD was made according to DSM-III-R, and was based on clinical interview of the patient and a relative, psychometric testing (including MMSE, Dementia Rating Scale and tests assessing memory, executive functions and visuospatial functioning) and physical examination. The Neuropsychiatric Inventory (NPI) was administered to all patients.
RESULTS: One or more psychiatric symptoms was reported in 95% of AD and 83% of PDD patients. Hallucinations were more severe in PD patients, while aberrant motor behavior, agitation, disinhibition, irritability, euphoria, and apathy were more severe in AD. In PDD, apathy was more common in mild Hoehn and Yahr stages, while delusions increased with more severe motor and cognitive disturbances. In PDD, only delusions correlated with the MMSE score.
CONCLUSIONS: Neuropsychiatric symptoms are common and severe in patients with PDD, with important implications for the management of these patients. AD and PDD patients have different neuropsychiatric profiles, suggesting different underlying mechanisms. Cognitive impairment, psychopathology, and motor features progress independently in PDD patients Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241724     DOI: 10.1002/1099-1166(200102)16:2<184::aid-gps304>3.0.co;2-k

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  28 in total

1.  Apathy in Parkinson's disease.

Authors:  G C Pluck; R G Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients.

Authors:  Roberto Erro; Gabriella Santangelo; Marina Picillo; Carmine Vitale; Marianna Amboni; Katia Longo; Angela Costagliola; Maria Teresa Pellecchia; Roberto Allocca; Anna De Rosa; Giuseppe De Michele; Lucio Santoro; Paolo Barone
Journal:  J Neurol       Date:  2012-02-07       Impact factor: 4.849

Review 3.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

4.  Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.

Authors:  Karina Stavitsky; Patrick McNamara; Raymon Durso; Erica Harris; Sanford Auerbach; Alice Cronin-Golomb
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

5.  Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients.

Authors:  Jesús Pérez-Pérez; Javier Pagonabarraga; Saül Martínez-Horta; Ramón Fernández-Bobadilla; Salvador Sierra; Berta Pascual-Sedano; Alexandre Gironell; Jaime Kulisevsky
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

Review 6.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

7.  Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress.

Authors:  D Aarsland; K Brønnick; U Ehrt; P P De Deyn; S Tekin; M Emre; J L Cummings
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07-04       Impact factor: 10.154

8.  Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: beyond cognition.

Authors:  Joanne M Hamilton; David P Salmon; Rema Raman; Lawrence A Hansen; Eliezer Masliah; Guerry M Peavy; Douglas Galasko
Journal:  Alzheimers Dement       Date:  2013-07-11       Impact factor: 21.566

9.  Apathy after hip fracture: a potential target for intervention to improve functional outcomes.

Authors:  Eric J Lenze; Michael C Munin; Mary Amanda Dew; Robert S Marin; Meryl A Butters; Elizabeth R Skidmore; Ellen M Whyte; Amy Begley; Charles F Reynolds
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

Review 10.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.